Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Perfusion CT scan
OTHER
3 trials
Sponsors
M.D. Anderson Cancer Center
, University of Oxford
, University Hospital, Tours
Conditions
Colorectal Cancer
Hepatic Metastases
Metastatic Colorectal Cancer
Renal Cell Carcinoma
Early Phase 1
PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases
NCT01410760
University of Oxford
Metastatic Colorectal Cancer
Start: 2011-04-30
Target: 40
Updated: 2012-06-20
Phase 2
Targeted Delivery of Chemotherapy With Ultrasound and Microbublles
Completed
NCT03458975
University Hospital, Tours
Colorectal Cancer, Hepatic Metastases
Start: 2019-10-01
End: 2022-09-30
Updated: 2023-01-09
Phase 3
Dynamic Contrast Enhancement Computed Tomography for Evaluating Tumor Perfusion in Patients With Metastatic Renal Cell Carcinoma Receiving Targeted Therapies: Renal Cell Carcinoma (RCC) Scramble
Active, not recruiting
NCT01224288
M.D. Anderson Cancer Center
Renal Cell Carcinoma
Start: 2011-01-05
End: 2029-04-30
Target: 120
Updated: 2025-11-07
Related Papers
FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer.
2014-07-09
54 citations